.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Healthtrust
Dow
Farmers Insurance
Julphar
US Department of Justice
Citi
Accenture
Covington

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,888,745

« Back to Dashboard

Which drugs does patent 8,888,745 protect, and when does it expire?


Patent 8,888,745 protects NEXPLANON and is included in one NDA.

This patent has twenty-two patent family members in nineteen countries.

Summary for Patent: 8,888,745

Title:Applicator for inserting an implant
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6) extending from the housing (3), and a handle (15) for grasping and maneuvering the applicator (1) and the cannula (6) during insertion of an implant (2). In accordance with the invention, the handle (15) extends above at least part of the length of the cannula (6). Such a handle facilitates insertion of the cannula and/or accurate positioning of the implant.
Inventor(s): Van Der Graaf; Iris Epkjen Hobo (Deventer, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL), Schmidt; Juergen (Herten, DE), Vertegaal; Hendricus Johannes (Hengelo, NL)
Assignee: Merck Sharp & Dohme B.V. (Haarlem, NL)
Application Number:11/795,796
Patent Claim Types:
see list of patent claims
Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Organon Usa Inc
NEXPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-002May 31, 2011RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,888,745

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100419Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050328
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077242

International Patent Family for Patent: 8,888,745

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Peru12162006► Subscribe
New Zealand556491► Subscribe
Norway20073749► Subscribe
Mexico2007008881► Subscribe
South Korea101241687► Subscribe
South Korea20070102718► Subscribe
Japan5015009► Subscribe
Japan2008528084► Subscribe
Israel184571► Subscribe
Hong Kong1114800► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
QuintilesIMS
Cipla
AstraZeneca
Argus Health
Fuji
Express Scripts
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot